AI assistant
Barclays PLC — Major Shareholding Notification 2023
Nov 2, 2023
5250_mrq_2023-11-02_dba63eff-dcb7-4719-bc36-22b777d49a3a.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information ![]()
RNS Number : 2146S
Barclays PLC
02 November 2023
| FORM 8.3 | |||||||
| PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY | |||||||
| A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR | |||||||
| MORE | |||||||
| Rule 8.3 of the Takeover Code (the "Code") | |||||||
| 1. | KEY INFORMATION | ||||||
| (a) | Full name of discloser: | Barclays PLC. | |||||
| (b) | Owner or controller of interest and short | ||||||
| positions disclosed, if different from 1(a): | |||||||
| (c) | Name of offeror/offeree in relation to whose | DECHRA PHARMACEUTICALS PLC | |||||
| relevant securities this form relates: | |||||||
| (d) | If an exempt fund manager connected with an | ||||||
| offeror/offeree, state this and specify identity of | |||||||
| offeror/offeree: | |||||||
| (e) | Date position held/dealing undertaken: | 01 Nov 2023 | |||||
| (f) | In addition to the company in 1(c) above, is the discloser making | NO | |||||
| disclosures in respect of any other party to the offer? | |||||||
| 2. | POSITIONS OF THE PERSON MAKING THE DISCLOSURE | ||||||
| (a) | Interests and short positions in the relevant securities of the offeror or offeree | ||||||
| to which the disclosure relates following the dealing(if any) | |||||||
| Class of relevant security: | 1p ordinary | ||||||
| Interests | Short Positions | ||||||
| Number | (%) | Number | (%) | ||||
| (1) | Relevant securities owned | ||||||
| and/or controlled: | 7,418,030 | 6.51% | 2,751,133 | 2.42% | |||
| (2) | Cash-settled derivatives: | ||||||
| and/or controlled: | 1,260,901 | 1.11% | 7,325,892 | 6.43% | |||
| (3) | Stock-settled derivatives (including options) | ||||||
| and agreements to purchase/sell: | 0 | 0.00% | 0 | 0.00% | |||
| TOTAL: | 8,678,931 | 7.62% | 10,077,025 | 8.85% | |||
| (b) | Rights to subscribe for new securities (including directors and other executive | ||||||
| options) | |||||||
| Class of relevant security in relation to | |||||||
| which subscription right exists | |||||||
| Details, including nature of the rights | |||||||
| concerned and relevant percentages: | |||||||
| 3. | DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER | ||||||
| (a) | Purchases and sales | ||||||
| Class of relevant | Purchase/sale | Number of | Price per unit | ||||
| security | securities | ||||||
| 1p ordinary | Purchase | 13,871 | 37.9176 GBP | ||||
| 1p ordinary | Purchase | 6,957 | 38.0000 GBP | ||||
| 1p ordinary | Purchase | 5,059 | 37.8976 GBP | ||||
| 1p ordinary | Purchase | 3,343 | 37.9014 GBP | ||||
| 1p ordinary | Purchase | 2,960 | 37.9892 GBP | ||||
| 1p ordinary | Purchase | 1,379 | 37.9565 GBP | ||||
| 1p ordinary | Purchase | 1,274 | 37.8479 GBP | ||||
| 1p ordinary | Purchase | 899 | 37.8907 GBP | ||||
| 1p ordinary | Purchase | 694 | 37.8964 GBP | ||||
| 1p ordinary | Purchase | 580 | 37.8519 GBP | ||||
| 1p ordinary | Purchase | 480 | 37.9062 GBP | ||||
| 1p ordinary | Purchase | 454 | 37.8663 GBP | ||||
| 1p ordinary | Purchase | 357 | 37.9400 GBP | ||||
| 1p ordinary | Purchase | 357 | 37.8600 GBP | ||||
| 1p ordinary | Purchase | 304 | 37.8400 GBP | ||||
| 1p ordinary | Purchase | 288 | 37.9100 GBP | ||||
| 1p ordinary | Purchase | 275 | 37.8762 GBP | ||||
| 1p ordinary | Purchase | 275 | 37.8800 GBP | ||||
| 1p ordinary | Purchase | 274 | 37.9070 GBP | ||||
| 1p ordinary | Purchase | 264 | 37.8844 GBP | ||||
| 1p ordinary | Purchase | 260 | 37.9264 GBP | ||||
| 1p ordinary | Purchase | 161 | 37.9300 GBP | ||||
| 1p ordinary | Purchase | 16 | 38.0600 GBP | ||||
| 1p ordinary | Sale | 55,740 | 37.8510 GBP | ||||
| 1p ordinary | Sale | 8,225 | 37.9304 GBP | ||||
| 1p ordinary | Sale | 1,578 | 37.8464 GBP | ||||
| 1p ordinary | Sale | 1,119 | 37.8508 GBP | ||||
| 1p ordinary | Sale | 1,041 | 37.8400 GBP | ||||
| 1p ordinary | Sale | 828 | 38.0000 GBP | ||||
| 1p ordinary | Sale | 604 | 37.8500 GBP | ||||
| 1p ordinary | Sale | 527 | 37.8600 GBP | ||||
| 1p ordinary | Sale | 345 | 37.9400 GBP | ||||
| 1p ordinary | Sale | 327 | 37.8294 GBP | ||||
| 1p ordinary | Sale | 275 | 37.8800 GBP | ||||
| 1p ordinary | Sale | 261 | 37.8722 GBP | ||||
| 1p ordinary | Sale | 12 | 37.9958 GBP | ||||
| 1p ordinary | Sale | 10 | 37.8160 GBP | ||||
| (b) | Cash-settled derivative transactions | ||||||
| Class of | Product | Nature of dealing | Number of | Price per | |||
| relevant | description | reference | unit | ||||
| security | securities | ||||||
| 1p ordinary | SWAP | Long | 10 | 37.8162 GBP | |||
| 1p ordinary | SWAP | Long | 12 | 37.9962 GBP | |||
| 1p ordinary | SWAP | Long | 16 | 37.9402 GBP | |||
| 1p ordinary | SWAP | Long | 256 | 38.0000 GBP | |||
| 1p ordinary | SWAP | Long | 411 | 37.8086 GBP | |||
| 1p ordinary | CFD | Long | 1,578 | 37.8464 GBP | |||
| 1p ordinary | SWAP | Long | 4,400 | 37.8410 GBP | |||
| 1p ordinary | SWAP | Long | 8,011 | 37.9384 GBP | |||
| 1p ordinary | SWAP | Long | 55,740 | 37.8510 GBP | |||
| 1p ordinary | SWAP | Short | 79 | 37.8968 GBP | |||
| 1p ordinary | SWAP | Short | 213 | 37.8600 GBP | |||
| 1p ordinary | SWAP | Short | 250 | 37.9486 GBP | |||
| 1p ordinary | SWAP | Short | 274 | 37.9070 GBP | |||
| 1p ordinary | CFD | Short | 480 | 37.9062 GBP | |||
| 1p ordinary | CFD | Short | 899 | 37.8907 GBP | |||
| 1p ordinary | SWAP | Short | 1,622 | 37.9754 GBP | |||
| 1p ordinary | CFD | Short | 1,927 | 37.9120 GBP | |||
| 1p ordinary | SWAP | Short | 2,000 | 37.9677 GBP | |||
| 1p ordinary | SWAP | Short | 2,745 | 37.9036 GBP | |||
| 1p ordinary | SWAP | Short | 3,343 | 37.9014 GBP | |||
| 1p ordinary | SWAP | Short | 5,974 | 37.9210 GBP | |||
| 1p ordinary | CFD | Short | 6,845 | 38.0000 GBP | |||
| 1p ordinary | SWAP | Short | 9,009 | 37.9089 GBP | |||
| (c) | Stock-settled derivative transactions (including options) | ||||||
| (i) | Writing, selling, purchasing or varying | ||||||
| Class | Product | Writing, | Number | Exercise | Type | Expiry | Option |
| of | description | purchasing, | of | price | date | money | |
| relevant | selling, | securities | per unit | paid/ | |||
| security | varying etc | to which | received | ||||
| option | per unit | ||||||
| relates | |||||||
| (ii) | Exercising | ||||||
| Class of relevant | Product description | Exercising/ exercised against | Number of | Exercise price per | |||
| security | securities | unit | |||||
| (d) | Other dealings (including subscribing for new securities) | ||||||
| Class of relevant | Nature of Dealings | Details | Price per unit (if | ||||
| security | applicable) | ||||||
| 4. | OTHER INFORMATION | ||||||
| (a) | Indemnity and other dealings arrangements | ||||||
| Details of any indemnity or option arrangement, or any agreement or understanding, | |||||||
| formal or informal, relating to relevant securities which may be an inducement to deal | |||||||
| or refrain from dealing entered into by the exempt principal trader making the disclosure and any party | |||||||
| to the offer or any person acting in concert with a party to the offer: | |||||||
| NONE | |||||||
| (b) | Agreements, arrangements or understandings relating to options or derivatives | ||||||
| Details of any agreement, arrangement or understanding, formal or informal, between | |||||||
| the person making the disclosure and any other person relating to: | |||||||
| (i) the voting rights of any relevant securities under any option; or | |||||||
| (ii) the voting rights of future acquisition or disposal of any relevant securities to which | |||||||
| any derivative is referenced: | |||||||
| NONE | |||||||
| (c) | Attachments | ||||||
| Is a Supplemental Form 8 (Open Positions) attached? | NO | ||||||
| Date of disclosure: | 02 Nov 2023 | ||||||
| Contact name: | Large Holdings Regulatory Operations | ||||||
| Telephone number: | 020 3134 7213 | ||||||
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETEAFFAEAADFFA